Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer
Open accessAbstract
Background & aims Identification of the hereditary nonpolyposis colorectal cancer (HNPCC) syndrome enables prevention of colorectal cancer (CRC) by means of colonoscopy and polypectomies. We evaluated the efficacy of screening in a controlled trial over 15 years.Methods Incidence of CRC and survival were compared in 2 cohorts of at-risk members of 22 families with HNPCC. Colonic screening at 3-year intervals was arranged for 133 subjects; 119 control subjects had no screening. Genetic testing was offered to subjects in whose families the causative mutation was known.Results CRC developed in 8 screened subjects (6%) compared with 19 control subjects (16 %; P = 0.014). The CRC rate was reduced by 62%. In mutation-positive subjects alone, the CRC rates were 18% in screened subjects and 41% in controls (P = 0.02). The decrease resulted from the removal of adenomas in 13 mutation-positive individuals (30%) and in 6 subjects with unknown mutation status (40%). All CRCs in the study group were local, causing no deaths, compared with 9 deaths caused by CRC in the controls. The overall death rates were 10 vs. 26 subjects in the study and control groups (P = 0.003), 4 vs. 12 in mutation-positive subjects (P = 0.05).Conclusions Colonoscopic screening at 3-year intervals more than halves the risk of CRC, prevents CRC deaths, and decreases overall mortality by about 65% in HNPCC families.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Screening for Lynch syndrome has been proven cost-effective, and surveillance for colon cancer with regular colonoscopies significantly decreases morbidity and mortality in affected patients.
“Screening has been proven cost-effective, and surveillance for colon cancer with regular colonoscopies significantly decreases morbidity and mortality in affected patients (60, 61).”
From Adrenocortical carcinoma (2014) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919 · see citing works
The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)
Vasen, H. F. A., Mecklin, J., Khan, P. M., & Lynch, H. T. (1991) · Diseases of the Colon & Rectum · doi:10.1007/bf02053699 · Cited by 2,146 · see citing works
Self-citationVasen, H. F. A., Wijnen, J., Menko, F. H., KLEIBEUKER, J. H., Taal, B. G., Griffioen, G. G., Nagengast, F. M., Meijers-Heijboer, E. H., Bertario, L., Varesco, L., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8612988 · Cited by 812 · see citing works
Peltomäki, P., & Vasen, H. F. A. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322509 · Cited by 746 · see citing works
Self-citationGermline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer
Miyaki, M., Konishi, M., Tanaka, K., Kikuchi‐Yanoshita, R., Muraoka, M., Yasuno, M., Igari, T., Koike, M., Chiba, M., & Mori, T. (1997) · Nature Genetics · doi:10.1038/ng1197-271 · Cited by 720 · see citing works
Cancer risk associated with germline DNA mismatch repair gene mutations
Dunlop, M. G. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.1.105 · Cited by 694 · see citing works
Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer
Järvinen, H., Mecklin, J., & Sistonen, P. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90688-6 · Cited by 514 · see citing works
Self-citationFounding mutations and Alu-mediated recombination in hereditary colon cancer
Nyström, M., Kristo, P., Nicolaides, N. C., Chang, S.-Y. P., Aaltonen, L. A., Moisio, A., Järvinen, H., Mecklin, J., Kinzler, K. W., Vogelstein, B., et al. (1995) · Nature Medicine · doi:10.1038/nm1195-1203 · Cited by 299 · see citing works
Self-citationNyström, M. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.6.763 · Cited by 260 · see citing works
Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome)
Vasen, H. F. A., Nagengast, F. M., & Khan, P. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91016-6 · Cited by 224 · see citing works
Hereditary non-polyposis colorectal cancer — morphologies, genes and mutations
Jass, J. R., Stewart, S. M., Stewart, J. E., et al. (1994) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(94)90016-7 · Cited by 144 · see citing works
Molecular Mechanisms Underlying Hereditary Nonpolyposis Colorectal Carcinoma
Rhyu, M. S. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.5.240 · Cited by 97 · see citing works
Prophylactic Colectomy in Patients with Hereditary Nonpolyposis Colorectal Cancer
Church, J. M. (1996) · Annals of Medicine · doi:10.3109/07853899608999111 · Cited by 93 · see citing works
Hereditary nonpolyposis colorectal cancer: results of long-term surveillance in 50 families
Vasen, H. F. A., Taal, B. G., Nagengast, F. M., et al. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00249-i · Cited by 92 · see citing works
Establishment of a human hemangiosarcoma cell line (ISO-HAS)
Masuzawa, M., Fujimura, T., Hamada, Y., Fujita, Y., Hara, H., Nishiyama, S., Katsuoka, K., Tamauchi, H., & Sakurai, Y. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990412)81:2 · Cited by 81 · see citing works
p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma
Safran, H. P., King, T. C., Choy, H., Gollerkeri, A. M., Kwakwa, H. A., Lopez, F., Cole, B. F., Myers, J., Tarpey, J. T., & Rosmarin, A. G. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960915)78:6 · Cited by 68 · see citing works
Davis, N. C., Evans, E. B., Cohen, J. R., et al. (1984) · Diseases of the Colon & Rectum · doi:10.1007/bf02554593 · Cited by 58 · see citing works
A century of progress in hereditary nonpolyposis colorectal cancer (lynch syndrome)
Thorson, A. G., Knezetic, J. A., & Lynch, H. T. (1999) · Diseases of the Colon & Rectum · doi:10.1007/bf02235175 · Cited by 39 · see citing works
Aggressive polyps in hereditary nonpolyposis colorectal cancer: Targets for screening
Ahlquist, D. A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90711-4 · Cited by 31 · see citing works
Goodkin, K., Fletcher, M., & Cohen, N. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90180-9 · Cited by 25 · see citing works
Hot flashes in postmenopausal women treated for breast carcinoma
Carpenter, J. S., Andrykowski, M. A., Cordova, M., Cunningham, L., Studts, J., McGrath, P., Kenady, D., Sloan, D., & Munn, R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980501)82:9
Flagged first, then by citations
Research works printed but not linked: 4
- Lynch HT, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 1996;78:1149- 1167.
- Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltoma ¨ki P, Mecklin J-P, Ja ¨rvinen HJ. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999;81:214-218.
- Vasen HFA, van Ballegooijen M, Buskens E, Kleibeuker JK, Taal BG, Griffioen G, Nagengast FM, Menko FH, Meera Khan P. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer 1998; 82:1632-1637.
- Holmberg M, Kristo P, Chadwicks RB, Mecklin J-P, Ja ¨rvinen HJ, de la Chapelle A, Nystro ¨m-Lahti M, Peltoma ¨ki P. Mutation sharing, predominant involvement of the MLH1 gene and description of four novel mutations in hereditary non-polyposis colorectal can- cer. Hum Mutat 1998;11:482 [Mutation Note 144; online 1997].
Cited by
Sorted by citations
WINAWER, S. (2003) · Gastroenterology · doi:10.1053/gast.2003.50044 · Cited by 2,143 · see citing works
Molecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052 · see citing works
Syngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L., & Burt, R. W. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.435 · Cited by 1,662 · see citing works
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Nakagawa, H., Sotamaa, K., Prior, T. W., Westman, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043146 · Cited by 1,408 · see citing works
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892 · see citing works
Adrenocortical carcinoma is a Lynch syndrome-associated cancer
Raymond, V. M., Everett, J. N., Furtado, L. V., Gustafson, S. L., Jungbluth, C. R., Gruber, S. B., Hammer, G. D., Stoffel, E. M., Greenson, J. K., Giordano, T. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.0988 · Cited by 208 · see citing works
Dinh, T. A., Rosner, B. I., Atwood, J. C., Boland, C. R., Syngal, S., Vasen, H. F. A., Gruber, S. B., & Burt, R. W. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0262 · Cited by 175 · see citing works
Toon, C. W., Walsh, M. D., Chou, A., Capper, D., Clarkson, A., Sioson, L., Clarke, S., Mead, S., Walters, R. J., Clendenning, M., et al. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31828f233d · Cited by 136 · see citing works
Pancreatic cancer in Lynch syndrome patients
Bujanda, L., & Herreros-Villanueva, M. (2017) · Journal of Cancer · doi:10.7150/jca.20750 · Cited by 57 · see citing works
Colorectal cancer screening in Lynch syndrome: Indication, techniques and future perspectives
Perrod, G., Rahmi, G., & Cellier, C. (2021) · Digestive Endoscopy · doi:10.1111/den.13702 · Cited by 28 · see citing works
The Role of Colonoscopy in the Management of Individuals with Lynch Syndrome: A Narrative Review
D’Angelo, V., Rega, D., Marone, P., Di Girolamo, E., Civiletti, C., Tatangelo, F., Duraturo, F., De Rosa, M., de Bellis, M., & Delrio, P. (2023) · Cancers · doi:10.3390/cancers15153780 · Cited by 3 · see citing works
- Authors
- Järvinen, H. J., Aarnio, M., Mustonen, H., Aktan–Collan, K., Aaltonen, L. A., Peltomäki, P., Chapelle, A. D. L., & Mecklin, J.
- Affiliations
- University of Helsinki (FI)
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2000-05
- Volume
- 118
- Issue
- 5
- Pages
- 829-834
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2156299764
- Cited by
- 1,337
- References
- 22
- Citations by year
- 2026: 19 · 2025: 24 · 2024: 26 · 2023: 31 · 2022: 22 · 2021: 37 · 2020: 41 · 2019: 45 · 2018: 46 · 2017: 43 · 2016: 49 · 2015: 48 · 2014: 70 · 2013: 75 · 2012: 51
- FWCI
- 28.50
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA67941, CA16058, P30CA016058)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Keywords
- Lynch syndrome, colorectal cancer screening, colonoscopy, polypectomy, colorectal adenoma, cancer prevention, genetic testing, colorectal cancer incidence, colorectal cancer mortality
- MeSH terms
- MutL Protein Homolog 1, Adult, Carrier Proteins, Colonoscopy, Colorectal Neoplasms, Hereditary Nonpolyposis, Female, Humans, Male, Mass Screening, Middle Aged, Mutation, Neoplasm Proteins, Nuclear Proteins, Prospective Studies, Risk, Sigmoidoscopy, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
